DOA
ARLZ

D'Orazio & Associates’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

D'Orazio & Associates’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,006
Closed -$1K – 369
2017
Q4 		$1K Hold
1,006
– – ﹤0.01% 322
2017
Q3 		$2K Hold
1,006
– – ﹤0.01% 260
2017
Q2 		$1K Buy
1,006
+288
+40% +$416 ﹤0.01% 331
2017
Q1 		$2K Buy
718
+500
+229% +$1.88K ﹤0.01% 281
2016
Q4 		$1K Hold
218
– – ﹤0.01% 269
2016
Q3 		$1K Hold
218
– – ﹤0.01% 279
2016
Q2 		$1K Hold
218
– – ﹤0.01% 291
2016
Q1 		$0 Buy
+218
New +$1.12K ﹤0.01% 334

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return

D'Orazio & Associates's ARLZ Position: Q1 2018 in Review

D'Orazio & Associates sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q1 2018, closing a stake of 1,006 shares — an estimated $1K sold.

D'Orazio & Associates first reported a position in ARLZ in Q1 2016 and held it in 8 quarters. The position peaked at $2K in Q3 2017. 56 funds tracked by Wall St. Rank hold ARLZ as of Q1 2018.

  • D'Orazio & Associates reported no remaining Aralez Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • D'Orazio & Associates sold 1,006 Aralez Pharmaceuticals Inc. shares in Q1 2018, an estimated $1K.
  • D'Orazio & Associates first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 8 quarters.
  • D'Orazio & Associates's Aralez Pharmaceuticals Inc. position peaked at $2K in Q3 2017.
  • 56 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2018.

Based on D'Orazio & Associates's 13F filing for Q1 2018, filed 4 May 2018.